Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

772 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Quantification of PD-L1 Expression with 18F-BMS-986192 PET/CT in Patients with Advanced-Stage Non-Small Cell Lung Cancer.
Huisman MC, Niemeijer AN, Windhorst AD, Schuit RC, Leung D, Hayes W, Poot A, Bahce I, Radonic T, Oprea-Lager DE, Hoekstra OS, Thunnissen E, Hendrikse NH, Smit EF, de Langen AJ, Boellaard R. Huisman MC, et al. Among authors: hayes w. J Nucl Med. 2020 Oct;61(10):1455-1460. doi: 10.2967/jnumed.119.240895. Epub 2020 Feb 14. J Nucl Med. 2020. PMID: 32060213 Free article.
Whole body PD-1 and PD-L1 positron emission tomography in patients with non-small-cell lung cancer.
Niemeijer AN, Leung D, Huisman MC, Bahce I, Hoekstra OS, van Dongen GAMS, Boellaard R, Du S, Hayes W, Smith R, Windhorst AD, Hendrikse NH, Poot A, Vugts DJ, Thunnissen E, Morin P, Lipovsek D, Donnelly DJ, Bonacorsi SJ, Velasquez LM, de Gruijl TD, Smit EF, de Langen AJ. Niemeijer AN, et al. Among authors: hayes w. Nat Commun. 2018 Nov 7;9(1):4664. doi: 10.1038/s41467-018-07131-y. Nat Commun. 2018. PMID: 30405135 Free PMC article. Clinical Trial.
Downregulation of 18F-FDG uptake in PET as an early pharmacodynamic effect in treatment of non-small cell lung cancer with the mTOR inhibitor everolimus.
Nogová L, Boellaard R, Kobe C, Hoetjes N, Zander T, Gross SH, Dimitrijevic S, Pellas T, Eschner W, Schmidt K, Bangard C, Hayes W, Thomas RK, Dietlein M, Giaccone G, Hoekstra OS, Lammertsma AA, Wolf J. Nogová L, et al. Among authors: hayes w. J Nucl Med. 2009 Nov;50(11):1815-9. doi: 10.2967/jnumed.109.065367. Epub 2009 Oct 16. J Nucl Med. 2009. PMID: 19837761 Free article. Clinical Trial.
Measuring response to therapy using FDG PET: semi-quantitative and full kinetic analysis.
Cheebsumon P, Velasquez LM, Hoekstra CJ, Hayes W, Kloet RW, Hoetjes NJ, Smit EF, Hoekstra OS, Lammertsma AA, Boellaard R. Cheebsumon P, et al. Among authors: hayes w. Eur J Nucl Med Mol Imaging. 2011 May;38(5):832-42. doi: 10.1007/s00259-010-1705-9. Epub 2011 Jan 6. Eur J Nucl Med Mol Imaging. 2011. PMID: 21210109 Free PMC article.
Synthesis and Preclinical Evaluation of a 68Ga-Labeled Adnectin, 68Ga-BMS-986192, as a PET Agent for Imaging PD-L1 Expression.
Robu S, Richter A, Gosmann D, Seidl C, Leung D, Hayes W, Cohen D, Morin P, Donnelly DJ, Lipovšek D, Bonacorsi SJ, Smith A, Steiger K, Aulehner C, Krackhardt AM, Weber WA. Robu S, et al. Among authors: hayes w. J Nucl Med. 2021 Sep 1;62(9):1228-1234. doi: 10.2967/jnumed.120.258384. Epub 2021 Jan 30. J Nucl Med. 2021. PMID: 33517324 Free PMC article.
Synthesis and Biologic Evaluation of a Novel 18F-Labeled Adnectin as a PET Radioligand for Imaging PD-L1 Expression.
Donnelly DJ, Smith RA, Morin P, Lipovšek D, Gokemeijer J, Cohen D, Lafont V, Tran T, Cole EL, Wright M, Kim J, Pena A, Kukral D, Dischino DD, Chow P, Gan J, Adelakun O, Wang XT, Cao K, Leung D, Bonacorsi SJ Jr, Hayes W. Donnelly DJ, et al. Among authors: hayes w. J Nucl Med. 2018 Mar;59(3):529-535. doi: 10.2967/jnumed.117.199596. Epub 2017 Oct 12. J Nucl Med. 2018. PMID: 29025984 Free article.
772 results